PRKN and cardiac hypertrophy: Of note, Parkin levels decline in hypertrophic cardiomyocytes, as well as mouse hearts, and overexpression of Parkin in mice blocked Ang-II-induced hypertrophy and improved heart function via boosting mitophagy, highlighting the importance of clearance of damaged mitochondria during cardiac hypertrophy (Sun et al., 2022).